High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature

Netherlands Journal of Medicine

Volumn 71, Issue 4, 2013, Pages 199-202

  D'Agnolo, H M A ^a   Drenth, J P H ^b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hepatitis; Methylprednisolone; Multiple sclerosis

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; DRUG MEGADOSE; ECHOGRAPHY; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; MULTIPLE SCLEROSIS;

ACUTE DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE;

EID: 84878441260     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Acar M, Gedizlioglu M, Koskderelioglu A, Ozturk F, Kilinc S, Talay N. Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse. Eur Neurol. 2012;68:20-2.
2. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 2008;71:129-35.
3. Geijteman E, Kramer M, Nanayakkara P. Episodes of shortness of breath induced by prednisone. Neth J Med. 2011;69:237-9.
4. Ribichini F, Tomai F, De Luca G, et al. Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. Am J Med. 2011;124:434-43.
5. Rivero Fernandez M, Riesco JM, Moreira VF, et al. [Recurrent acute liver toxicity from intravenous methylprednisolone]. Rev Esp Enferm Dig. 2008;100:720-3.
6. Gutkowski K, Chwist A, Hartleb M. Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon. 2011;11:656-61.
7. Topal F, Ozaslan E, Akbulut S, Kucukazman M, Yuksel O, Altiparmak E. Methylprednisolone-induced toxic hepatitis. Ann Pharmacother. 2006;40:1868-71.
8. Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4:489-99.
9. Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis. 2007;11:459-75, v.
10. Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10:1018-23.
11. Goodin DS, Frohman EM, Garmany GP, Jr., et al. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology. 2002;58:169-78.
12. Weinshenker BG, O'Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878-86.
13. Furutama D, Kimura F, Shinoda K, Maeda T, Tanaka T, Ohsawa N. Recurrent high-dose intravenous methylprednisolone succinate pulse therapy-induced hepatopathy in a patient with multiple sclerosis. Med Princ Pract. 2011;20:291-3.
14. Das D, Graham I, Rose J. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis. Indian J Gastroenterol. 2006;25:314-6.
15. Hofstee HM, Nanayakkara PW, Stehouwer CD. Acute hepatitis related to prednisolone. Eur J Intern Med. 2005;16:209-10.